Michael Kope
Fondatore presso Cyclarity Therapeutics, Inc.
Profilo
Michael Kope founded Cyclarity Therapeutics, Inc., where he worked as Chief Executive Officer-Corporate Affairs.
Mr. Kope also formerly worked at Aridis Pharmaceuticals, Inc., as Vice President & Corporate Development Consultant.
Mr. Kope received his graduate degree in 1990 from the University of Michigan.
Posizioni attive di Michael Kope
| Società | Posizione | Inizio |
|---|---|---|
Cyclarity Therapeutics, Inc.
 Cyclarity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyclarity Therapeutics, Inc. provides technology to treat, cure, and reverse atherosclerosis. It develops simple and direct interventions targeting toxic forms of cholesterol using rationally designed molecules to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. The company was founded by Michael Kope and Matthew O?Connor and is headquartered in Mountain View, CA. | Fondatore | - |
Precedenti posizioni note di Michael Kope
| Società | Posizione | Fine |
|---|---|---|
| ARIDIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di Michael Kope
| University of Michigan | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ARIDIS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Cyclarity Therapeutics, Inc.
Cyclarity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cyclarity Therapeutics, Inc. provides technology to treat, cure, and reverse atherosclerosis. It develops simple and direct interventions targeting toxic forms of cholesterol using rationally designed molecules to provide the first true disease-modifying treatments for age-related diseases such as atherosclerosis, hypercholesterolemia, heart failure, and macular degeneration. The company was founded by Michael Kope and Matthew O?Connor and is headquartered in Mountain View, CA. | Commercial Services |
- Borsa valori
- Insiders
- Michael Kope
